Abstract
This chapter examines the characteristics and use of containment systems to perform various applications of freeze-drying. Specific consideration is given to containment system design, effects on mass and heat transfer, containment of microorganisms, and recommendations for the future application of containment options.
An assessment is made of previously characterized containment systems developed for freeze-drying which include a reusable aluminum box and the disposable Gore Lyoguard. Common design features of both were determined and a suitable, cost-effective, off the shelf alternative identified in the form of sterilization pouches. Further consideration is given to previous studies that have characterized and compared the effects on mass and heat transfer that barriers cause by increasing resistance to water vapor movement. In addition, the subsequent increases to heat transfer brought about by resistance to mass transfer are also further considered.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Wang W (2000) Lyophilisation and development of solid protein pharmaceuticals. Int J Pharm 203:1–60
Trappler E (1995) Lyophilisation. In: Groves MJ, Murty R (eds) Aseptic pharmaceutical manufacturing II applications for the 1990s. Interpharm Press Incorporated, Buffalo Grove, IL
Snowman JW (1995) Lyophilisation under barrier technology. In: Groves MJ, Murty R (eds) Aseptic pharmaceutical manufacturing II applications for the 1990s. Interpharm Press Incorporated, Buffalo Grove, IL
Akers MJ (2010) Freeze-dry (lyophilisation) processing. In: Sterile drug products formulation, packaging, manufacturing and quality. Informa Healthcare, New York, NY
Suzuki O, Tanaka K, Watanabe N, Takeda M (2003) Design criteria and containment evaluation for pharmaceutical containment systems in aseptic dosage form manufacturing facilities. Pharm Technol 27:24–31
Taylor R, Boardman CFB, Wallis RG (1978) Sterile freeze-drying in an unclean environment. J Appl Chem Biotechnol 28:213–216
Gassler M, Rey L (2004) Development of a new concept for bulk freeze-drying: lyoguard freeze-dry packaging. In: Rey L, May JC (eds) Freeze-drying/lyophilization of pharmaceutical and biological products. 2nd edition, Informa Healthcare, New York, NY
Dunkelberg H, Rohmann S (2006) Test to determine sterile integrity of wrapped medical products at a probability of recontamination of 1:1,000,000. Infect Control Hosp Epidemiol 27(4):367–371
Nolan PJ (2004) Sterile medical device package development. In: Standard handbook of biomedical engineering and design. McGraw-Hill, New York, NY
Dunkelberg H, Schmelz U (2009) Determination of the efficacy of sterile barrier systems against microbial challenges during transport and storage. Infect Control Hosp Epidemiol 30(2):179–183
DuPont (2009) DuPont medical packaging guide technical reference guide
Pikal MJ (1985) Use of laboratory data in freeze-drying process design: heat and mass transfer coefficients and the computer simulation of freeze-drying. J Parenter Sci Technol 39:115–138
Cherry CLA, Millward H, Cooper R, Landon J (2014) A novel approach to sterile pharmaceutical freeze-drying. Pharm Dev Technol 19(1):73–81
Konstantinidis AK, Kuu W, Otten L, Nail SL, Sever RR (2011) Controlled nucleation in freeze-drying: effects on pore size in the dried product layer, mass transfer resistance, and primary drying rate. J Pharm Sci 100(8):3453–3470
Kuu WY, Hardwick LM, Akers MJ (2006) Rapid determination of dry layer mass transfer resistance for various pharmaceutical formulations during primary drying using product temperature profiles. Int J Pharm 313:99–113
Tang X, Nail SL, Pikal MJ (2006) Evaluation of manometric temperature measurement, a process analytical tool for freeze-drying: Part II measurement of dry layer resistance. AAPS PharmSciTech 7(4):E77
Lu X, Pikal MJ (2004) Freeze-drying of mannitol-trehalose-sodium chloride based formulations: the impact of annealing on dry layer resistance to mass transfer and cake structure. Pharm Dev Technol 9(1):85–95
Patel SM, Pikal MJ (2010) Freeze-drying in novel container systems: characterisation of heat and mass transfer in glass syringes. J Pharm Sci 99(7):3188–3204
Adams GDJ (1991) The loss of substrate from a vial during freeze-drying using Escherichia coli as a trace organism. J Chem Technol Biotechnol 52:511–518
Adams GDJ (1994) Freeze-drying of biohazardous products. In: Hambleton P, Melling J, Salusbury T (eds) Biosafety in industrial biotechnology. Chapman and Hall, London
Stein CD, Rogers H (1950) Recovery of viable microorganisms and viruses from vapors removed from frozen suspensions of biologic material during lyophilisation. Am J Vet Res 11:339–344
Reitman M, Moss ML, Bruce Harstad J, Alg RL, Gross NH (1954) Potential infectious hazards of laboratory techniques. J Bacteriol 65(5):541–544
Busby D (1959) Contamination of apparatus during freeze-drying. J Hyg (London) 57:403–406
Barbaree JM, Sanchez A (1982) Cross contamination during lyophilisation. Cryobiology 19:443–447
Cammack KA, Adams GDJ (1985) Formulation and storage. In: Spier RE, Griffiths JB (eds) Animal cell biotechnology, vol 2. Academic Press Inc. Ltd., London
Adams GDJ (1996) Lyophilisation of vaccines. In: Robinson A, Farrar G, Wiblin C (eds) Methods in molecular medicine: vaccine protocols. Humana Press Inc., Totowa, NJ
Cherry CLA, Cooper R, Millward H, Landon J (2015) Proof of concept: containment systems that prevent freeze-dryer contamination when lyophilizing Escherichia coli (JM 109). Drying Technol 33(4):466–470
Patel SM, Pikal MJ (2011) Emerging freeze-drying process development and scale-up issues. AAPS PharmSciTech 12(1):372
Mayeresse Y, de Cupere V, Veillon R, Brendle J (2009) Considerations for transferring a bulk freeze-drying process from a glass container to a tray. Pharm Eng 29:36
Cherry CLA (2013) Development of novel containment systems for freeze-drying. Doctoral dissertation, Cardiff Metropolitan University
Nakamura T, Inatomi T, Sekiyama E, Ang LPK, Yokoi N, Kinoshita S (2006) Novel clinical application of sterilised, freeze-dried amniotic membrane to treat patients with pterygium. Acta Ophthalmol Scand 84:401–405
Libera RD, Barreto de Melo B, Lima A, Haapalainen EF, Cristovam P, Gomes JAP (2008) Assessment of the use of cryopreserved freeze-dried amniotic membrane (AM) for the reconstruction of ocular surface in rabbit model. Arq Bras Oftalmol 71(5):669–673
Jackson DW, Grood ES, Wilcox P, Butler DL, Simon TM, Holden JP (1988) The effects of processing techniques on the mechanical properties of bone-anterior cruciate ligament-bone allografts. Am J Sports Med 16(2):101–105
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Cherry, C. (2019). Containment Options for the Freeze-Drying of Biological Entities and Potent Materials. In: Ward, K., Matejtschuk, P. (eds) Lyophilization of Pharmaceuticals and Biologicals. Methods in Pharmacology and Toxicology. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-8928-7_6
Download citation
DOI: https://doi.org/10.1007/978-1-4939-8928-7_6
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-8927-0
Online ISBN: 978-1-4939-8928-7
eBook Packages: Springer Protocols